Reimbursement Challenges and Solutions with Molecular Biomarker TestingVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.
Listen as Dr. Michaelis presents her opinion on success and failure approach to treatment of polycythemia vera. Supported through funding from Incyte
Laura C. Michaelis, MD, Medical College of Wisconsin describes why cytoreductive therapy is important to discuss with patients with polycthemia vera.Supported through funding from Incyte